EPISODE · Mar 30, 2026 · 29 MIN
The Nurse View: Evolution of Anti-HER2 Therapies in Gastroesophageal Adenocarcinoma
from Keeping Current CME
Are you familiar with the most common treatment-related events of emerging HER2-targeted therapies for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/nurse-view-evolution-anti-her2-therapies-gastroesophageal-2026a100096j?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
The Nurse View: Evolution of Anti-HER2 Therapies in Gastroesophageal Adenocarcinoma
0:00
29:43
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 29 minutes long.
When was this Keeping Current CME episode published?
This episode was published on March 30, 2026.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!